1. Home
  2. TIL vs ILPT Comparison

TIL vs ILPT Comparison

Compare TIL & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • ILPT
  • Stock Information
  • Founded
  • TIL 2018
  • ILPT 2017
  • Country
  • TIL United States
  • ILPT United States
  • Employees
  • TIL N/A
  • ILPT N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • ILPT Real Estate Investment Trusts
  • Sector
  • TIL Health Care
  • ILPT Real Estate
  • Exchange
  • TIL Nasdaq
  • ILPT Nasdaq
  • Market Cap
  • TIL 218.4M
  • ILPT 235.1M
  • IPO Year
  • TIL 2021
  • ILPT 2018
  • Fundamental
  • Price
  • TIL $26.50
  • ILPT $3.62
  • Analyst Decision
  • TIL Buy
  • ILPT Buy
  • Analyst Count
  • TIL 4
  • ILPT 2
  • Target Price
  • TIL $100.33
  • ILPT $10.00
  • AVG Volume (30 Days)
  • TIL 154.7K
  • ILPT 461.3K
  • Earning Date
  • TIL 11-13-2024
  • ILPT 10-29-2024
  • Dividend Yield
  • TIL N/A
  • ILPT 1.10%
  • EPS Growth
  • TIL N/A
  • ILPT N/A
  • EPS
  • TIL N/A
  • ILPT N/A
  • Revenue
  • TIL N/A
  • ILPT $440,696,000.00
  • Revenue This Year
  • TIL N/A
  • ILPT N/A
  • Revenue Next Year
  • TIL $2.64
  • ILPT $6.87
  • P/E Ratio
  • TIL N/A
  • ILPT N/A
  • Revenue Growth
  • TIL N/A
  • ILPT 1.36
  • 52 Week Low
  • TIL $6.08
  • ILPT $2.81
  • 52 Week High
  • TIL $92.00
  • ILPT $5.45
  • Technical
  • Relative Strength Index (RSI)
  • TIL 38.29
  • ILPT 34.50
  • Support Level
  • TIL $24.31
  • ILPT $3.52
  • Resistance Level
  • TIL $37.24
  • ILPT $3.76
  • Average True Range (ATR)
  • TIL 4.02
  • ILPT 0.20
  • MACD
  • TIL 0.26
  • ILPT 0.02
  • Stochastic Oscillator
  • TIL 10.85
  • ILPT 58.75

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About ILPT Industrial Logistics Properties Trust of Beneficial Interest

Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.

Share on Social Networks: